Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

3D Printed Scaffolds for Stabilization and Local Therapeutic Delivery in Bone Metastases

EF 2020-21

Résumé
There has been a recent rise in cancer occurrence and increase in the risk of metastatic cancer, which is the spreading of cancer in the body from a primary source. Bone is the third most common site for metastases, with breast and prostate tumors often the primary source. Bone metastases can cause pain, instability and fractures. The current gold standard of treatment involves removing large sections of the bone that have been affected by the cancer. One limitation of surgical resection is that very small amounts of residual tumor are often left behind. With patients' survival time increasing, they are faced with high risk of recurrence and re-operation. Bone tumor resections often cause critical size defects which cannot self-repair and require additional support for stabilization and bone regeneration. Our team has been developing devices that can both support bone formation and locally deliver drugs that will eliminate residual tumor cells. 3D printing is an ideal method for this as it is cost-effective and produces unique, patient-specific geometries. We aim to generate composite scaffolds from two polymer types: a stiff one that contains mineral which supports bone repair, and a sponge-like polymer that can be loaded with therapeutics for local delivery. We aim to 1) test the scaffolds' mechanical integrity, 2) test the scaffolds' ability to deliver chemotherapeutics to breast and prostate cancer cells in vitro and 3) test the scaffolds in a rat model of bone metastasis where we will monitor bone repair, mechanical stability and inhibition of cancer recurrence following resection. Based on our preliminary work, we expect that the composite scaffolds will drive bone regeneration and successfully deliver sufficient chemotherapeutics to eradicate the residual cancer.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
449614
Name
Pitaru Audrey A
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
3D Printed Scaffolds for Stabilization and Local Therapeutic Delivery in Bone Metastases
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
3d Printing; Animal Model; Bone Metastases; Cisplatin; Doxorubicin; Local Delivery; Nanoporous Filament; Orthopaedic Surgery; Paclitaxel; Scaffolds
Abstract
There has been a recent rise in cancer occurrence and increase in the risk of metastatic cancer, which is the spreading of cancer in the body from a primary source. Bone is the third most common site for metastases, with breast and prostate tumors often the primary source. Bone metastases can cause pain, instability and fractures. The current gold standard of treatment involves removing large sections of the bone that have been affected by the cancer. One limitation of surgical resection is that very small amounts of residual tumor are often left behind. With patients' survival time increasing, they are faced with high risk of recurrence and re-operation. Bone tumor resections often cause critical size defects which cannot self-repair and require additional support for stabilization and bone regeneration. Our team has been developing devices that can both support bone formation and locally deliver drugs that will eliminate residual tumor cells. 3D printing is an ideal method for this as it is cost-effective and produces unique, patient-specific geometries. We aim to generate composite scaffolds from two polymer types: a stiff one that contains mineral which supports bone repair, and a sponge-like polymer that can be loaded with therapeutics for local delivery. We aim to 1) test the scaffolds' mechanical integrity, 2) test the scaffolds' ability to deliver chemotherapeutics to breast and prostate cancer cells in vitro and 3) test the scaffolds in a rat model of bone metastasis where we will monitor bone repair, mechanical stability and inhibition of cancer recurrence following resection. Based on our preliminary work, we expect that the composite scaffolds will drive bone regeneration and successfully deliver sufficient chemotherapeutics to eradicate the residual cancer.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pitaru, Audrey A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~